BrioHealth Solutions
Kevin Hynes has over 20 years of experience in various engineering and management roles. Kevin is currently working as the Vice President of R&D, Software Engineering at BrioHealth Solutions. Before that, they served as the Vice President of Engineering at Vicarious Surgical Inc. From 2018 to 2022, they worked as the Senior Director of Research and Development at Dräger, overseeing a team of 200+ people and managing a 50M USD budget. Prior to that, they held the position of Director of Software Engineering at Dräger, leading a multinational team of over 115 people focused on Agile development.
From 2014 to 2016, Kevin was the Senior Software Manager at Passport Systems, Inc., where they managed software development across various product lines. Kevin also worked as a Software Engineering Manager at Medtronic from 2009 to 2014, introducing Agile processes and leading software development for a surgical imaging system.
Kevin began their career as a Senior Software Engineer at Goodrich in 2007, where they developed and enhanced aerospace imaging products. Kevin then worked as a Principal Software Engineer at Acme Packet, Inc. from 2003 to 2007, leading the Security Applications Group. Prior to that, they were a Principal Software Engineer at WaterCove Networks, focusing on IP infrastructure development. Kevin started their career as a Senior Software Engineer at Bay Networks, where they contributed to the development of routing software.
Kevin Hynes attended the University of New Hampshire from 1989 to 1993, where they obtained a BS in Electrical and Computer Engineering. In 2018, they completed a Mini-MBA program at Bentley University. Kevin also obtained a Project Management Certificate from Northern Essex Community College in 2011. Kevin Hynes graduated from Pinkerton Academy in 1989 with a High School degree. Additionally, they received a CSM certification from the Scrum Alliance in 2013.
BrioHealth Solutions
1 followers
About BrioHealth Solutions We are a global team of like-minded Med-Tech professionals focused on patient centric solutions in a collaborative environment leading to excellent outcomes. We have developed an advanced and unique heart failure therapy technology in the BrioVAD® Left Ventricular Assist System (LVAS). We are introducing the BrioVAD LVAS to Heart Failure clinicians for use with the large number of indicated and untreated patients who could benefit from chronic mechanical circulatory support. The initiation of our INNOVATE™ Trial in the US is only the beginning. We are building a team to develop advanced technology intended to further improve patient outcomes, increase therapy acceptance, and enabling chronic MCS therapy to be accessible to more patients across the globe. About the BrioVAD® Left Ventricular Assist System (LVAS)* Leveraging innovative pump design with long-blade rotor technology, the BrioVAD® LVAS has been designed to create an optimal blood flow path, boosting cardiac output, while minimizing complications. BrioVAD® LVAS’s patient-centric design enhances patient comfort and promotes a sense of vitality and improved well-being. *The BrioVAD® LVAS is an Investigational Device and limited by Federal law to investigational use.